JAK2 and myeloproliferative neoplasm: In addition, the type II arginine methyltransferase, protein arginine methyltransferase 5 (PRMT5) that mediates dimethylation of arginine residues within histones H2A, H3, and H4, contributes to the JAK2 mutant-induced MPN phenotype.